Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.7370
-0.0330 (-4.29%)
At close: Nov 7, 2025, 4:00 PM EST
0.7518
+0.0148 (2.01%)
After-hours: Nov 7, 2025, 7:45 PM EST
Longeveron Market Cap
Longeveron has a market cap or net worth of $15.52 million as of November 7, 2025. Its market cap has decreased by -51.31% in one year.
Market Cap
15.52M
Enterprise Value
7.26M
1-Year Change
-51.31%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $15.52M, a decrease of -91.00%. That is a compound annual growth rate of -39.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 15.52M | -39.53% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | 172.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |